{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:26:45Z","timestamp":1795004805374,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD084478"],"award-info":[{"award-number":["R01HD084478"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adenomyosis is defined as the presence of ectopic nests of endometrial glands and stroma within the myometrium. Adenomyosis is a common cause of dysmenorrhea, menorrhagia, and chronic pelvic pain but is often underdiagnosed. Despite its prevalence and severity of symptoms, its pathogenesis and etiology are poorly understood. Our previous study showed that aberrant activation of \u03b2-catenin results in adenomyosis through epithelial\u2013mesenchymal transition. Using transcriptomic and ChIP-seq analysis, we identified activation of TGF-\u03b2 signaling in the uteri of mutant mice that expressed dominant stabilized \u03b2-catenin in the uterus. There was a strong positive correlation between \u03b2-catenin and TGF-\u03b22 proteins in women with adenomyosis. Furthermore, treatment with pirfenidone, a TGF-\u03b2 inhibitor, increased E-cadherin expression and reduced cell invasiveness in Ishikawa cells with nuclear \u03b2-catenin. Our results suggest that \u03b2-catenin activates TGF-\u03b2-induced epithelial\u2013mesenchymal transition in adenomyosis. This finding describes the molecular pathogenesis of adenomyosis and the use of TGF-\u03b2 as a potential therapeutic target for adenomyosis.<\/jats:p>","DOI":"10.1038\/s12276-020-00514-6","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T04:03:48Z","timestamp":1602734628000},"page":"1754-1765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["\u03b2-catenin activates TGF-\u03b2-induced epithelial\u2013mesenchymal transition in adenomyosis"],"prefix":"10.1038","volume":"52","author":[{"given":"Jung-Yoon","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3414-8949","authenticated-orcid":false,"given":"Bon Jeong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong","family":"Il Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Sub","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Mook","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maketo M.","family":"Taketo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-6478","authenticated-orcid":false,"given":"Jae-Wook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"514_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1148\/rg.251045060","volume":"25","author":"K Tamai","year":"2005","unstructured":"Tamai, K. et al. MR imaging findings of adenomyosis: correlation with histopathologic features and diagnostic pitfalls. Radiographics 25, 21\u201340 (2005).","journal-title":"Radiographics"},{"key":"514_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/humupd\/4.4.312","volume":"4","author":"A Ferenczy","year":"1998","unstructured":"Ferenczy, A. Pathophysiology of adenomyosis. Hum. Reprod. Update 4, 312\u2013322 (1998).","journal-title":"Hum. Reprod. Update"},{"key":"514_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bpobgyn.2006.01.017","volume":"20","author":"P Vercellini","year":"2006","unstructured":"Vercellini, P. et al. Adenomyosis: epidemiological factors. Best. Pr. Res Clin. Obstet. Gynaecol. 20, 465\u2013477 (2006).","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"514_CR4","first-page":"688","volume":"95","author":"M Levgur","year":"2000","unstructured":"Levgur, M., Abadi, M. A. & Tucker, A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet. Gynecol. 95, 688\u2013691 (2000).","journal-title":"Obstet. Gynecol."},{"key":"514_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000068385","volume":"54","author":"A Sammour","year":"2002","unstructured":"Sammour, A., Pirwany, I., Usubutun, A., Arseneau, J. & Tulandi, T. Correlations between extent and spread of adenomyosis and clinical symptoms. Gynecol. Obstet. Invest. 54, 213\u2013216 (2002).","journal-title":"Gynecol. Obstet. Invest"},{"key":"514_CR6","doi-asserted-by":"publisher","first-page":"786132","DOI":"10.1155\/2012\/786132","volume":"2012","author":"S Campo","year":"2012","unstructured":"Campo, S., Campo, V. & Benagiano, G. Infertility and adenomyosis. Obstet. Gynecol. Int. 2012, 786132 (2012).","journal-title":"Obstet. Gynecol. Int."},{"key":"514_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.rbmo.2012.02.013","volume":"24","author":"LS Louis","year":"2012","unstructured":"Louis, L. S., Saso, S., Chatterjee, J., Barsoum, E. & Al-Samarrai, M. Adenomyosis and infertility. Reprod. Biomed. Online 24, 586 (2012). author reply 587.","journal-title":"Reprod. Biomed. Online"},{"key":"514_CR8","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/humrep\/16.11.2427","volume":"16","author":"M Bazot","year":"2001","unstructured":"Bazot, M. et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum. Reprod. 16, 2427\u20132433 (2001).","journal-title":"Hum. Reprod."},{"key":"514_CR9","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.fertnstert.2011.02.051","volume":"95","author":"MK Mehasseb","year":"2011","unstructured":"Mehasseb, M. K. et al. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil. Steril. 95, 2228\u20132235 2235. e2221 (2011).","journal-title":"Fertil. Steril."},{"key":"514_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.maturitas.2008.12.018","volume":"62","author":"AE Schindler","year":"2009","unstructured":"Schindler, A. E. Progestogen deficiency and endometrial cancer risk. Maturitas 62, 334\u2013337 (2009).","journal-title":"Maturitas"},{"key":"514_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bpobgyn.2006.01.003","volume":"20","author":"P Greaves","year":"2006","unstructured":"Greaves, P. & White, I. N. Experimental adenomyosis. Best. Pr. Res Clin. Obstet. Gynaecol. 20, 503\u2013510 (2006).","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"514_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000145724","volume":"116","author":"T Mori","year":"1983","unstructured":"Mori, T. & Nagasawa, H. Mechanisms of development of prolactin-induced adenomyosis in mice. Acta Anat. (Basel) 116, 46\u201354 (1983).","journal-title":"Acta Anat. (Basel)"},{"key":"514_CR13","first-page":"121","volume":"74","author":"PL Ostrander","year":"1985","unstructured":"Ostrander, P. L., Mills, K. T. & Bern, H. A. Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure. J. Natl Cancer Inst. 74, 121\u2013135 (1985).","journal-title":"J. Natl Cancer Inst."},{"key":"514_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0002-9440(10)61733-6","volume":"159","author":"E Parrott","year":"2001","unstructured":"Parrott, E., Butterworth, M., Green, A., White, I. N. & Greaves, P. Adenomyosis-a result of disordered stromal differentiation. Am. J. Pathol. 159, 623\u2013630 (2001).","journal-title":"Am. J. Pathol."},{"key":"514_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/path.4224","volume":"231","author":"SJ Oh","year":"2013","unstructured":"Oh, S. J. et al. beta-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition. J. Pathol. 231, 210\u2013222 (2013).","journal-title":"J. Pathol."},{"key":"514_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/onc.2008.363","volume":"28","author":"JW Jeong","year":"2009","unstructured":"Jeong, J. W. et al. beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene 28, 31\u201340 (2009).","journal-title":"Oncogene"},{"key":"514_CR17","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1094291","volume":"303","author":"WJ Nelson","year":"2004","unstructured":"Nelson, W. J. & Nusse, R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303, 1483\u20131487 (2004).","journal-title":"Science"},{"key":"514_CR18","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","volume":"16","author":"H Aberle","year":"1997","unstructured":"Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797\u20133804 (1997).","journal-title":"EMBO J."},{"key":"514_CR19","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1101\/gad.10.20.2527","volume":"10","author":"JR Miller","year":"1996","unstructured":"Miller, J. R. & Moon, R. T. Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev. 10, 2527\u20132539 (1996).","journal-title":"Genes Dev."},{"key":"514_CR20","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.8259518","volume":"262","author":"B Rubinfeld","year":"1993","unstructured":"Rubinfeld, B. et al. Association of the APC gene product with beta-catenin. Science 262, 1731\u20131734 (1993).","journal-title":"Science"},{"key":"514_CR21","first-page":"1344","volume":"58","author":"J Palacios","year":"1998","unstructured":"Palacios, J. & Gamallo, C. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res. 58, 1344\u20131347 (1998).","journal-title":"Cancer Res."},{"key":"514_CR22","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1038\/sj.onc.1205924","volume":"21","author":"G Moreno-Bueno","year":"2002","unstructured":"Moreno-Bueno, G. et al. Abnormalities of the APC\/beta-catenin pathway in endometrial cancer. Oncogene 21, 7981\u20137990 (2002).","journal-title":"Oncogene"},{"key":"514_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers, H. Wnt\/beta-catenin signaling in development and disease. Cell 127, 469\u2013480 (2006).","journal-title":"Cell"},{"key":"514_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","volume":"28","author":"O Schmalhofer","year":"2009","unstructured":"Schmalhofer, O., Brabletz, S. & Brabletz, T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 28, 151\u2013166 (2009).","journal-title":"Cancer Metastasis Rev."},{"key":"514_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<128::AID-PATH839>3.0.CO;2-Q","volume":"182","author":"M Ilyas","year":"1997","unstructured":"Ilyas, M. & Tomlinson, I. P. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J. Pathol. 182, 128\u2013137 (1997).","journal-title":"J. Pathol."},{"key":"514_CR26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M. & Nieto, M. A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 119, 1438\u20131449 (2009).","journal-title":"J. Clin. Invest."},{"key":"514_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265\u2013273 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"514_CR28","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420\u20131428 (2009).","journal-title":"J. Clin. Invest"},{"key":"514_CR29","first-page":"461","volume":"150","author":"R Gaetje","year":"1997","unstructured":"Gaetje, R., Kotzian, S., Herrmann, G., Baumann, R. & Starzinski-Powitz, A. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am. J. Pathol. 150, 461\u2013467 (1997).","journal-title":"Am. J. Pathol."},{"key":"514_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/path.2761","volume":"222","author":"YJ Chen","year":"2010","unstructured":"Chen, Y. J. et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. J. Pathol. 222, 261\u2013270 (2010).","journal-title":"J. Pathol."},{"key":"514_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442\u2013454 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"514_CR32","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/j.1349-7006.2007.00550.x","volume":"98","author":"A Moustakas","year":"2007","unstructured":"Moustakas, A. & Heldin, C. H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98, 1512\u20131520 (2007).","journal-title":"Cancer Sci."},{"key":"514_CR33","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.2106\/00004623-200100001-00005","volume":"83","author":"A Letamendia","year":"2001","unstructured":"Letamendia, A., Labbe, E. & Attisano, L. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J. Bone Jt. Surg. Am. 83, S31\u2013S39 (2001).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"514_CR34","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.biocel.2010.02.011","volume":"42","author":"P Minoo","year":"2010","unstructured":"Minoo, P. & Li, C. Cross-talk between transforming growth factor-beta and Wingless\/Int pathways in lung development and disease. Int. J. Biochem. Cell Biol. 42, 809\u2013812 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"514_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156\u2013172 (2009).","journal-title":"Cell Res."},{"key":"514_CR36","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1242\/jcs.003129","volume":"120","author":"A Nawshad","year":"2007","unstructured":"Nawshad, A., Medici, D., Liu, C. C. & Hay, E. D. TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J. Cell Sci. 120, 1646\u20131653 (2007).","journal-title":"J. Cell Sci."},{"key":"514_CR37","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1093\/emboj\/18.21.5931","volume":"18","author":"N Harada","year":"1999","unstructured":"Harada, N. et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18, 5931\u20135942 (1999).","journal-title":"EMBO J."},{"key":"514_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0002-9378(16)33500-1","volume":"122","author":"RW Noyes","year":"1975","unstructured":"Noyes, R. W., Hertig, A. T. & Rock, J. Dating the endometrial biopsy. Am. J. Obstet. Gynecol. 122, 262\u2013263 (1975).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"514_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005537","volume":"11","author":"TH Kim","year":"2015","unstructured":"Kim, T. H. et al. ARID1A Is Essential for Endometrial Function during Early Pregnancy. PLoS Genet. 11, e1005537 (2015).","journal-title":"PLoS Genet."},{"key":"514_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/ng1901","volume":"38","author":"JS Carroll","year":"2006","unstructured":"Carroll, J. S. et al. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38, 1289\u20131297 (2006).","journal-title":"Nat. Genet"},{"key":"514_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030087","volume":"3","author":"CY Lin","year":"2007","unstructured":"Lin, C. Y. et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 3, e87 (2007).","journal-title":"PLoS Genet."},{"key":"514_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1095\/biolreprod.109.081307","volume":"82","author":"TH Kim","year":"2010","unstructured":"Kim, T. H., Lee, D. K., Franco, H. L., Lydon, J. P. & Jeong, J. W. ERBB receptor feedback inhibitor 1 regulation of estrogen receptor activity is critical for uterine implantation in mice. Biol. Reprod. 82, 706\u2013713 (2010).","journal-title":"Biol. Reprod."},{"key":"514_CR43","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.1158\/0008-5472.CAN-14-0794","volume":"74","author":"TH Kim","year":"2014","unstructured":"Kim, T. H. et al. Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation. Cancer Res. 74, 7371\u20137382 (2014).","journal-title":"Cancer Res."},{"key":"514_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0301-2115(03)00244-6","volume":"111","author":"N Inagaki","year":"2003","unstructured":"Inagaki, N., Ung, L., Otani, T., Wilkinson, D. & Lopata, A. Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur. J. Obstet. Gynecol. Reprod. Biol. 111, 197\u2013203 (2003).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"514_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/humrep\/dew230","volume":"31","author":"M Shen","year":"2016","unstructured":"Shen, M., Liu, X., Zhang, H. & Guo, S. W. Transforming growth factor beta1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice. Hum. Reprod. 31, 355\u2013369 (2016).","journal-title":"Hum. Reprod."},{"key":"514_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5487\/TR.2010.26.4.245","volume":"26","author":"H Son","year":"2010","unstructured":"Son, H. & Moon, A. Epithelial-mesenchymal Transition and Cell Invasion. Toxicol. Res. 26, 245\u2013252 (2010).","journal-title":"Toxicol. Res."},{"key":"514_CR47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ydbio.2005.09.045","volume":"288","author":"NA Arango","year":"2005","unstructured":"Arango, N. A. et al. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol. 288, 276\u2013283 (2005).","journal-title":"Dev. Biol."},{"key":"514_CR48","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1095\/biolreprod.104.033837","volume":"72","author":"J Li","year":"2005","unstructured":"Li, J. et al. Inhibition of the beta-catenin signaling pathway in blastocyst and uterus during the window of implantation in mice. Biol. Reprod. 72, 700\u2013706 (2005).","journal-title":"Biol. Reprod."},{"key":"514_CR49","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1073\/pnas.0500612102","volume":"102","author":"OA Mohamed","year":"2005","unstructured":"Mohamed, O. A. et al. Uterine Wnt\/beta-catenin signaling is required for implantation. Proc. Natl Acad. Sci. USA 102, 8579\u20138584 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"514_CR50","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massague","year":"2012","unstructured":"Massague, J. TGFbeta signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616\u2013630 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"514_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1095\/biolreprod.114.125146","volume":"92","author":"Y Gao","year":"2015","unstructured":"Gao, Y. et al. Constitutive activation of transforming growth factor Beta receptor 1 in the mouse uterus impairs uterine morphology and function. Biol. Reprod. 92, 34 (2015).","journal-title":"Biol. Reprod."},{"key":"514_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002320","volume":"7","author":"Q Li","year":"2011","unstructured":"Li, Q. et al. Transforming growth factor beta receptor type 1 is essential for female reproductive tract integrity and function. PLoS Genet. 7, e1002320 (2011).","journal-title":"PLoS Genet."},{"key":"514_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/humupd\/dmh061","volume":"11","author":"JL Juengel","year":"2005","unstructured":"Juengel, J. L. & McNatty, K. P. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum. Reprod. Update 11, 143\u2013160 (2005).","journal-title":"Hum. Reprod. Update"},{"key":"514_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ceb.2014.09.001","volume":"31","author":"R Derynck","year":"2014","unstructured":"Derynck, R., Muthusamy, B. P. & Saeteurn, K. Y. Signaling pathway cooperation in TGF-beta-induced epithelial-mesenchymal transition. Curr. Opin. Cell Biol. 31, 56\u201366 (2014).","journal-title":"Curr. Opin. Cell Biol."},{"key":"514_CR55","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/humrep\/dew018","volume":"31","author":"X Liu","year":"2016","unstructured":"Liu, X., Shen, M., Qi, Q., Zhang, H. & Guo, S. W. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis. Hum. Reprod. 31, 734\u2013749 (2016).","journal-title":"Hum. Reprod."},{"key":"514_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"514_CR57","doi-asserted-by":"crossref","unstructured":"Das, V., Bhattacharya, S., Chikkaputtaiah, C., Hazra, S. & Pal, M. The basics of epithelial-mesenchymal transition (EMT): a study from a structure, dynamics, and functional perspective. J. Cell Physiol. 234, 14535\u201314555 (2019).","DOI":"10.1002\/jcp.28160"},{"key":"514_CR58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fped.2019.00176","volume":"7","author":"Y Lecarpentier","year":"2019","unstructured":"Lecarpentier, Y., Gourrier, E., Gobert, V. & Vallee, A. Bronchopulmonary dysplasia: crosstalk between PPARgamma, WNT\/beta-catenin and TGF-beta pathways: the potential therapeutic role of PPARgamma agonists. Front. Pediatr. 7, 176 (2019).","journal-title":"Front. Pediatr."},{"key":"514_CR59","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/ATVBAHA.110.220061","volume":"31","author":"JH Chen","year":"2011","unstructured":"Chen, J. H., Chen, W. L., Sider, K. L., Yip, C. Y. & Simmons, C. A. beta-catenin mediates mechanically regulated, transforming growth factor-beta1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler. Thromb. Vasc. Biol. 31, 590\u2013597 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"514_CR60","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0022-4731(90)90306-D","volume":"35","author":"JD Croxtall","year":"1990","unstructured":"Croxtall, J. D., Elder, M. G. & White, J. O. Hormonal control of proliferation in the Ishikawa endometrial adenocarcinoma cell line. J. Steroid Biochem. 35, 665\u2013669 (1990).","journal-title":"J. Steroid Biochem."},{"key":"514_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1523-1755.1998.00962.x","volume":"54","author":"T Shimizu","year":"1998","unstructured":"Shimizu, T. et al. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney. Kidney Int. 54, 99\u2013109 (1998).","journal-title":"Kidney Int."},{"key":"514_CR62","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.healun.2004.11.002","volume":"24","author":"H Zhou","year":"2005","unstructured":"Zhou, H., Latham, C. W., Zander, D. S., Margolin, S. B. & Visner, G. A. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts. J. Heart Lung Transpl. 24, 1577\u20131585 (2005).","journal-title":"J. Heart Lung Transpl."},{"key":"514_CR63","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr.","year":"2014","unstructured":"King, T. E. Jr. et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2083\u20132092 (2014).","journal-title":"N. Engl. J. Med."},{"key":"514_CR64","first-page":"367","volume":"291","author":"SN Iyer","year":"1999","unstructured":"Iyer, S. N., Gurujeyalakshmi, G. & Giri, S. N. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J. Pharm. Exp. Ther. 291, 367\u2013373 (1999).","journal-title":"J. Pharm. Exp. Ther."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00514-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T02:04:19Z","timestamp":1650247459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00514-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1038\/s12276-020-00514-6","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}